These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25884980)

  • 1. Lactobacillus gasseri SBT2055 suppresses fatty acid release through enlargement of fat emulsion size in vitro and promotes fecal fat excretion in healthy Japanese subjects.
    Ogawa A; Kobayashi T; Sakai F; Kadooka Y; Kawasaki Y
    Lipids Health Dis; 2015 Mar; 14():20. PubMed ID: 25884980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lactobacillus gasseri SBT2055 reduces postprandial and fasting serum non-esterified fatty acid levels in Japanese hypertriacylglycerolemic subjects.
    Ogawa A; Kadooka Y; Kato K; Shirouchi B; Sato M
    Lipids Health Dis; 2014 Feb; 13():36. PubMed ID: 24548293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial.
    Kadooka Y; Sato M; Ogawa A; Miyoshi M; Uenishi H; Ogawa H; Ikuyama K; Kagoshima M; Tsuchida T
    Br J Nutr; 2013 Nov; 110(9):1696-703. PubMed ID: 23614897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Administration of Lactobacillus gasseri SBT2055 suppresses macrophage infiltration into adipose tissue in diet-induced obese mice.
    Ukibe K; Miyoshi M; Kadooka Y
    Br J Nutr; 2015 Oct; 114(8):1180-7. PubMed ID: 26299683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure.
    Shirouchi B; Nagao K; Umegatani M; Shiraishi A; Morita Y; Kai S; Yanagita T; Ogawa A; Kadooka Y; Sato M
    Br J Nutr; 2016 Aug; 116(3):451-8. PubMed ID: 27267802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-obesity effect of Lactobacillus gasseri SBT2055 accompanied by inhibition of pro-inflammatory gene expression in the visceral adipose tissue in diet-induced obese mice.
    Miyoshi M; Ogawa A; Higurashi S; Kadooka Y
    Eur J Nutr; 2014; 53(2):599-606. PubMed ID: 23917447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of rotavirus-induced diarrhea by preferential secretion of IgA in breast milk via maternal administration of Lactobacillus gasseri SBT2055.
    Kadooka Y; Tominari K; Sakai F; Yasui H
    J Pediatr Gastroenterol Nutr; 2012 Jul; 55(1):66-71. PubMed ID: 22395190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial.
    Kadooka Y; Sato M; Imaizumi K; Ogawa A; Ikuyama K; Akai Y; Okano M; Kagoshima M; Tsuchida T
    Eur J Clin Nutr; 2010 Jun; 64(6):636-43. PubMed ID: 20216555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactobacillus gasseri SBT2055 inhibits adipose tissue inflammation and intestinal permeability in mice fed a high-fat diet.
    Kawano M; Miyoshi M; Ogawa A; Sakai F; Kadooka Y
    J Nutr Sci; 2016; 5():e23. PubMed ID: 27293560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lactobacillus gasseri NT decreased visceral fat through enhancement of lipid excretion in feces of KK-A(y) mice.
    Yonejima Y; Ushida K; Mori Y
    Biosci Biotechnol Biochem; 2013; 77(11):2312-5. PubMed ID: 24200800
    [TBL] [Abstract][Full Text] [Related]  

  • 11.
    Kobatake E; Iwama Y; Arai T; Tsukisaka Y; Kabuki T
    Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults.
    Olivares M; Díaz-Ropero MA; Gómez N; Lara-Villoslada F; Sierra S; Maldonado JA; Martín R; López-Huertas E; Rodríguez JM; Xaus J
    Int J Food Microbiol; 2006 Mar; 107(2):104-11. PubMed ID: 16271414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intake of
    Kobatake E; Iwama Y; Arai T; Shioya N; Kise M; Kabuki T
    Front Nutr; 2022; 9():1063584. PubMed ID: 36570128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model.
    Niibo M; Shirouchi B; Umegatani M; Morita Y; Ogawa A; Sakai F; Kadooka Y; Sato M
    J Dairy Sci; 2019 Feb; 102(2):997-1006. PubMed ID: 30471910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lactobacillus gasseri SBT2055 induces TGF-β expression in dendritic cells and activates TLR2 signal to produce IgA in the small intestine.
    Sakai F; Hosoya T; Ono-Ohmachi A; Ukibe K; Ogawa A; Moriya T; Kadooka Y; Shiozaki T; Nakagawa H; Nakayama Y; Miyazaki T
    PLoS One; 2014; 9(8):e105370. PubMed ID: 25144744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects and mechanisms of prolongevity induced by Lactobacillus gasseri SBT2055 in Caenorhabditis elegans.
    Nakagawa H; Shiozaki T; Kobatake E; Hosoya T; Moriya T; Sakai F; Taru H; Miyazaki T
    Aging Cell; 2016 Apr; 15(2):227-36. PubMed ID: 26710940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mouse Models for Assessing the Protective Efficacy of Lactobacillus gasseri SBT2055 against Helicobacter suis Infection Associated with the Development of Gastric Mucosa-Associated Lymphoid Tissue Lymphoma.
    Matsui H; Takahashi T; Øverby A; Murayama SY; Yoshida H; Yamamoto Y; Nishiyama K; Seto Y; Takahashi T; Mukai T; Nakamura M
    Helicobacter; 2015 Aug; 20(4):291-8. PubMed ID: 25627811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of respiratory syncytial virus infection with probiotic lactic acid bacterium Lactobacillus gasseri SBT2055.
    Eguchi K; Fujitani N; Nakagawa H; Miyazaki T
    Sci Rep; 2019 Mar; 9(1):4812. PubMed ID: 30886158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Milk fermented by Lactobacillus gasseri SBT2055 influences adipocyte size via inhibition of dietary fat absorption in Zucker rats.
    Hamad EM; Sato M; Uzu K; Yoshida T; Higashi S; Kawakami H; Kadooka Y; Matsuyama H; Abd El-Gawad IA; Imaizumi K
    Br J Nutr; 2009 Mar; 101(5):716-24. PubMed ID: 18684338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of high-lipase pancreatin on fecal fat, neutral sterol, bile acid, and short-chain fatty acid excretion in patients with pancreatic insufficiency resulting from chronic pancreatitis.
    Nakamura T; Tandoh Y; Terada A; Yamada N; Watanabe T; Kaji A; Imamura K; Kikuchi H; Suda T
    Int J Pancreatol; 1998 Feb; 23(1):63-70. PubMed ID: 9520092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.